𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The changing importance of prognostic factors in breast cancer during long-term follow-up

✍ Scribed by P. Lipponen; S. Aaltomaa; M. Eskelinen; V.-M. Kosma; S. Marin; K. Syrjänen

Publisher
John Wiley and Sons
Year
1992
Tongue
French
Weight
550 KB
Volume
51
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The long-term prognostic significance of
The long-term prognostic significance of the thymidine labelling index in breast cancer
✍ M. Tubiana; M. H. Pejovic; N. Chavaudra; G. Contesso; E. P. Malaise 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 406 KB

## Abstract A prospective study of the prognostic significance of the labelling index (LI) was undertaken in 1972. The LI of the primary tumor was measured consecutively on 128 patients with mammary carcinoma at the time of initial treatment, following __in vitro__ incubation of specimens with trit

Further evaluation of the prognostic val
Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up
✍ Anne M. Uyterlinde; Jan P. A. Baak; Nellie W. Schipper; Hans Peterse; Erna Matze 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 635 KB

The added prognostic value of cellular DNA content compared with single and combined morphometric factors and classical parameters such as tumor size, nodal status, histologic grade and estrogen receptor (ER) content was investigated in 225 consecutive breast-cancer patients with long follow-up. Of

Prognostic factors for patients with sta
Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment : Results of Long-Term Follow-up
✍ Oliver Zivanovic; Richard R. Barakat; Paul J. Sabbatini; Carol L. Brown; Jason A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

## Abstract ## BACKGROUND. The aim was to determine the long‐term outcome for patients with FIGO stage IV epithelial ovarian carcinoma (EOC) treated with intraperitoneal (IP) chemotherapy after second‐look assessment. ## METHODS. By using data from a retrospective cohort of 433 patients who rece